Meng; Fanying

Patent Applications and Registrations

Patent applications and USPTO patent grants for Meng; Fanying.The latest application filed is for "akr1c3 inhibitor and medical use".

Company Profile

1.9.12

Meng; Fanying - San Francisco CA
Meng; Fanying - South San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Akr1c3 Inhibitor And Medical Use App 20220251021 - Duan; Jianxin ; et al.	2022-08-11
Fluorine-containing Compound And Anti-cancer Medical Use Thereof App 20220119429 - Duan; Jianxin ; et al.	2022-04-21
Use Of Compound In Drug For Preventing, Treating, Or Alleviating Pain App 20210283151 - Duan; Jianxin ; et al.	2021-09-16
Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancer Grant 9,254,299 - Hart , et al. February 9, 2	2016-02-09
Administration Of Hypoxia Activated Prodrugs In Combination With Chk1 Inhibitors For Treating Cancer App 20150005263 - Hart; Charles ; et al.	2015-01-01
Hypoxia Activated Prodrugs And Mtor Inhibitors For Treating Cancer App 20150005262 - Hart; Charles ; et al.	2015-01-01
Antagonists of MCP-1 function and methods of use thereof Grant 7,297,696 - Laborde , et al. November 20, 2	2007-11-20
Antagonists of MCP-1 function and methods of use thereof Grant 6,998,407 - Laborde , et al. February 14, 2	2006-02-14
Antagonists of MCP-1 function and methods of use thereof Grant 6,992,086 - Laborde , et al. January 31, 2	2006-01-31
Antagonist of MCP-1 function, and compositions and methods of use thereof Grant 6,962,926 - Laborde , et al. November 8, 2	2005-11-08
Antagonists of MCP-1 function and methods of use thereof App 20050054668 - Laborde, Edgardo ; et al.	2005-03-10
Antagonists of MCP-1 function and methods of use thereof Grant 6,809,113 - Laborde , et al. October 26, 2	2004-10-26
Antagonist of MCP-1 function, and compositions and methods of use thereof App 20040198719 - Laborde, Edgardo ; et al.	2004-10-07
Antagonists of MCP-1 function and methods of use thereof App 20040127513 - Laborde, Edgardo ; et al.	2004-07-01
Antagonists of MCP-1 function and methods of use thereof App 20040077680 - Laborde, Edgardo ; et al.	2004-04-22
Antagonists of MCP-1 function and methods of use thereof Grant 6,677,365 - Laborde , et al. January 13, 2	2004-01-13
Antagonists of MCP-1 function and methods of use thereof Grant 6,670,364 - Laborde , et al. December 30, 2	2003-12-30
Antagonists of MCP-1 function and methods of use thereof App 20030105085 - Laborde, Edgardo ; et al.	2003-06-05
Antagonists of MCP-1 function and methods of use thereof App 20030096705 - Laborde, Edgardo ; et al.	2003-05-22
Antagonists of MCP-1 function and methods of use thereof App 20030092728 - Laborde, Edgardo ; et al.	2003-05-15
Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents Grant 6,506,739 - Herr , et al. January 14, 2	2003-01-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.